68-2

81/110

) Murayama K, Shimura M, Liu Z, Okazaki Y, Ohtake A: Recent topics: the diagnosis, molec‑ular genesis, and treatment of mitochondrial diseases. J Hum Genet, 2019; 64: 113-125.) Eguchi H, Okazaki Y: Next-Generation Sequencing for Genetic Diagnosis of Heredi‑tary Colorectal Cancer and Polyposis Syndrome. in “Recent Advances in the Treatment of Colorectal Cancer” Springer, 2019; p.115-125. ) Agata H, Sumita Y, Hidaka T, Kagami H, Asahina I: Intra-Bone Marrow Administra‑tion of Mesenchymal Stem/Stromal Cells Is a Promising Approach for Treating Osteopo‑rosis. Stem Cells International Volume 2019, Article ID 4214281) I T, Sumita Y, Yoshida T, Honma R, Iwatake M, Raudales JLM, Shizuno T, Kuroshima S, Masuda H, Seki M, Tran SD, Asahara T, Asahina I: Anti-inflammatory and vasculo‑genic conditioning of peripheral blood mono‑nuclear cells reinforces their therapeutic poten‑tial for radiation-injured salivary glands., Stem Cell Res Ther, 2019; 10: 304.) Kuroshima S, Nakajima K, Sasaki M, I T, Sumita Y, Asahara T, Asahina I, Sawase T: Systemic administration of quality- and quan‑tity-controlled PBMNCs reduces bisphospho‑nate-related osteonecrosis of jaw-like lesions in mice. Stem Cell Res Ther, 2019; 10: 209. ) Narahara S, Sakai E, Kadowaki T, Yama‑guchi Y, Narahara H, Okamoto K, Asahina I, Tsukuba T: KBTBD11, a novel BTB-Kelch protein, is a negative regulator of osteoclasto‑genesis through controlling Cullin3-mediated ubiquitination of NFATc1. Sci Rep, 2019; 9: 21) Nakayama S, Shimonaka S, Elahi M, Nishioka K, Oji Y, Matsumoto SE, Li Y, Yoshino H, Mogushi K, Hatano T, Sato T, Ikura T, Ito N, Motoi Y, Hattori N: Tau aggregation and seeding analyses of two novel MAPT vari‑ants found in patients with motor neuron disease and progressive parkinsonism. Neuro‑biol Aging, 2019; 84: 240.e13-240.e22. 22) Nakazato K, Mogushi K, Kayamori K, Tsuchiya M, Takahashi KI, Sumino J, Michi Y, Yoda T, Uzawa N: Glucose metabolism changes during the development and progression of oral tongue squamous cell carcinomas. Oncol Lett, 2019; 18: 1372-1380. 23) Takenouchi T, Wei FY, Suzuki H, Uehara T, Takahashi T, Okazaki Y, Kosaki K, Tomi‑zawa K: Noninvasive diagnosis of TRIT1- related mitochondrial disorder by measuring i6 A37 and ms2 i6 A37 modifications in tRNAs from blood. Am J Med Genet A, 2019; 179: 1609-1614. 24) Ochiai N, Nakachi Y, Yokoo T, Ichihara T, Eriksson T, Yonemoto Y, Kato T, Ogata H, Fujimoto N, Kobayashi Y, Udagawa N, Kaku S, Ueki T, Okazaki Y, Takahashi N, Suda T: Murine osteoclasts secrete serine protease HtrA1 capable of degrading osteoprotegerin in the bone microenvironment. Commun Biol, 2019; 2: 86.＊ 25) Yoshida R, Watanabe C, Yokoyama S, Inuzuka M, Yotsumoto J, Arai M, Nakamura S, Regis‑tration Committee of the Japanese HBOC Consortium: Analysis of clinical characteris‑tics of breast cancer patients with the Japa‑nese founder mutation BRCA1 L63X. Onco‑target, 2019; 10: 3276-3284.＊ 26) Shimada S, Yoshida R, Nakashima E, Kitagawa D, Gomi N, Horii R, Takeuchi S, Ashihara Y, Kita M, Akiyama F, Ohno S, Saito M, Arai M: Five screening-detected breast cancer cases in initially disease-free BRCA1 or BRCA2 mutation carriers. Breast Cancer, 2019; 26: 846-851. 27) Shimada S, Mogushi K, Akiyama Y, Furuyama T, Watanabe S, Ogura T, Ogawa K, Ono H, Mitsunori Y, Ban D, Kudo A, Arii S, Tanabe M, Wands JR, Tanaka S: Comprehensive molecular and immunological characteriza‑tion of hepatocellular carcinoma. EBioMedi‑cine, 2019; 40: 457-470. 28) Shimura M, Nozawa N, Ogawa-Tominaga M, Fushimi T, Tajika M, Ichimoto K, Matsunaga A, Tsuruoka T, Kishita Y, Ishii T, Takahashi K, Tanaka T, Nakajima M, Okazaki Y, Ohtake A, Murayama K: Effects of 5-aminolevulinic acid and sodium ferrous citrate on fibroblasts from individuals with mitochondrial diseases. Sci Rep, 2019; 9: 10549.〈Reviews〉 1〈Books〉 1Oral and Maxillofacial Surgery〈Original Articles〉 1 2 3 4173